[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-332643-105":59,"doc-detail-332643-en":134},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":127,"head_meta":129,"extra_data":131,"updated_unix":133},105,"en","tattoos-and-risk-of-hematologic-cancer-a-population-based-case-control-study-in-utah","Tattoos and Risk of Hematologic Cancer - A Population-Based Case-Control Study in Utah","","Tattooing is common in the United States, affecting about one-third of adults, and its prevalence continues to rise. Tattooing may expose individuals to carcinogens and trigger inflammatory and immune responses, raising concerns about hematologic cancer risk. A population-based case-control study evaluated tattooing exposure among 820 cases and 8200 controls aged 18–79 using multivariable-adjusted logistic regression. Results showed no clear overall associations for Hodgkin lymphoma, non-Hodgkin lymphoma, or myeloid neoplasms, but suggestive increased risk patterns in age-restricted analyses.",{"@graph":69,"@context":126},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/tattoos-and-risk-of-hematologic-cancer-a-population-based-case-control-study-in-utah/332643/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/tattoos-and-risk-of-hematologic-cancer-a-population-based-case-control-study-in-utah/332643.png","ImageObject",300,407,{"name":92,"@type":93},"River Wang","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-04","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":24},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118,122],{"name":109,"@type":110,"acceptedAnswer":111},"What was the goal of the study on tattoos and hematologic cancer?","Question",{"text":112,"@type":113},"To assess whether tattooing is associated with the risk of hematologic cancers using a population-based case-control design in Utah.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were tattoo exposure and cancer risk analyzed?",{"text":117,"@type":113},"The study calculated odds ratios and 95% confidence intervals using multivariable-adjusted logistic regression models comparing 820 cases with 8200 frequency-matched controls.",{"name":119,"@type":110,"acceptedAnswer":120},"Did tattooing show an overall association with hematologic cancer risk?",{"text":121,"@type":113},"Overall analyses did not show clear patterns linking tattoo receipt to risk of Hodgkin lymphoma, non-Hodgkin lymphoma, or myeloid neoplasms.",{"name":123,"@type":110,"acceptedAnswer":124},"What specific findings were observed in subgroup analyses?",{"text":125,"@type":113},"Among ages 20–60 years, tattoo receipt and tattoos 10+ years prior were associated with an aggregated group of rarer mature B-cell non-Hodgkin lymphomas, with also elevated but imprecise risks for certain 10+ year latency outcomes.","https://schema.org",{"og:url":83,"og:type":128,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":130,"canonical":83},"index,follow",{"doc_id":132,"site_id":62},332643,1790179652,{"code":4,"msg":5,"data":135},{"doc_id":132,"user_id":136,"nickname":92,"user_avatar":137,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":138,"file_id":139,"file_url":140,"file_type":141,"file_size":142,"view_count":24,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":143,"language":144,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":145,"faqs":146,"seo_title":147,"seo_description":67,"update_tm":148,"read_time":149,"preview_page_count":4},1099514067438,"https://ap-avatar.wpscdn.com/avatar/100002539ee87300030?x-image-process=image/resize,m_fixed,w_180,h_180&k=1780474512215547542","Cancer Medicine  \nRESEARCH ARTICLE  OPEN ACCESS   \nTattoos and Risk of Hematologic Cancer:  \nA Population-Based Case–Control Study in Utah  \nRachel D. McCarty1,2  | Britton Trabert1,3 | David Kriebel4 | Morgan M. Millar1,5,6  | Brenda M. Birmann7 |  \nLaurie Grieshober1,2 | Mollie E. Barnard1,2,8 | Lindsay J. Collin1,2  | Katherine A. Lawson-Michod1,2  | Brody Gibson1,2 | Jenna Sawatzki1 | Marjorie Carter6 | Valerie Yoder6 | Jeffrey A. Gilreath1 | Paul J. Shami1 | Jennifer A. Doherty1   \n1Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA | 2Department of Population Health Sciences Spencer Fox Eccles School of Medicine, University of Utah Intermountain Healthcare, University of Utah, Salt Lake City, Utah, USA | 3Department of Obstetrics and Gynecology, Spencer Fox Eccles School of Medicine, University of Utah, Salt Lake City, Utah, USA | 4Lowell Center for Sustainable Production, University of Massachusetts Lowell, Lowell, Massachusetts, USA | 5Department of Internal Medicine, University of Utah, Salt Lake City, Utah, USA | 6Utah Cancer Registry, University of Utah, Salt Lake City, Utah, USA | 7Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA | 8Slone Epidemiology Center, Boston University Chobanian and Avedisian School of Medicine, Boston, Massachusetts, USA  \nCorrespondence: Rachel D. McCarty ([rachel.mccarty@hci.utah.edu](rachel.mccarty@hci.utah.edu))  \nReceived: 9 April 2024 | Revised: 26 August 2024 | Accepted: 12 September 2024  \nFunding: We acknowledge the direct financial support for the research reported in this publication provided by the Huntsman Cancer Foundation, the Huntsman Cancer Institute Melanoma Center, and the Cancer Control and Population Sciences (CCPS) Program at Huntsman Cancer Institute. We also acknowledge support by the National Cancer Institute of the National Institutes of Health (NIH) under Award Number P30CA042014 . The Utah Cancer Registry is funded by the National Cancer Institute's SEER Program, Contract No. HHSN261201800016I, the US Centers for Disease Control and Prevention's National Program of Cancer Registries, Cooperative Agreement No. NU58DP007131, with additional support from the University of Utah and Huntsman Cancer Foundation. Data collection and management via REDCap was supported by UL1TR002538 NCATS/NIH. The Utah Cancer Registry is funded by the NCI SEER Program, Contract No. HHSN261201800016I, the US Centers for Disease Control and Prevention's National Program of Cancer Registries, Cooperative Agreement No. NU58DP007131, with additional support from the University of Utah and Huntsman Cancer Foundation. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.  \nKeywords: epidemiology | leukemia | lymphoid neoplasms | lymphoma | myeloid neoplasms | tattoos  \nABSTRACT  \nBackground: Approximately one-third of US adults have a tattoo, and the prevalence is increasing. Tattooing can result in longterm exposure to carcinogens and inflammatory and immune responses.  \nMethods: We examined tattooing and risk of hematologic cancers in a population-based case–control study with 820 cases diagnosed 2019–2021 and 8200 frequency-matched controls, ages 18–79years. We calculated odds ratios (OR) and 95% confidence intervals (CI) using multivariable-adjusted logistic regression models.  \nResults: The prevalence of tattooing was 22% among Hodgkin lymphoma (HL) cases, 11% among non-Hodgkin lymphoma (NHL) cases, 16% among myeloid neoplasm cases, and 15% among controls. Though there were no clear patterns of associations between ever receiving a tattoo and risk of HL, NHL, or myeloid neoplasms overall, in analyses restricted to ages 20–60 years, ever receiving a tattoo (OR 2.06 [95% CI 1.01, 4.20]) and receiving a tattoo 10+ years prior (OR 2.64 [95% CI 1.23, 5.68]) were associated with an aggregated group of rarer ma","cbCaip3FJsNt5iRh","https://ap.wps.com/l/cbCaip3FJsNt5iRh","pdf",352356,11,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusions\n# Introduction","[{\"question\":\"What was the goal of the study on tattoos and hematologic cancer?\",\"answer\":\"To assess whether tattooing is associated with the risk of hematologic cancers using a population-based case-control design in Utah.\"},{\"question\":\"How were tattoo exposure and cancer risk analyzed?\",\"answer\":\"The study calculated odds ratios and 95% confidence intervals using multivariable-adjusted logistic regression models comparing 820 cases with 8200 frequency-matched controls.\"},{\"question\":\"Did tattooing show an overall association with hematologic cancer risk?\",\"answer\":\"Overall analyses did not show clear patterns linking tattoo receipt to risk of Hodgkin lymphoma, non-Hodgkin lymphoma, or myeloid neoplasms.\"},{\"question\":\"What specific findings were observed in subgroup analyses?\",\"answer\":\"Among ages 20–60 years, tattoo receipt and tattoos 10+ years prior were associated with an aggregated group of rarer mature B-cell non-Hodgkin lymphomas, with also elevated but imprecise risks for certain 10+ year latency outcomes.\"}]","Tattoos and Risk of Hematologic Cancer - A Population-Based Case-Control Study in Utah | PDF",1789998985,28]